Adcock Ingram to Delist Amidst Corporate Changes
Adcock Ingram is set to delist from the JSE as Natco Pharma partners with Bidvest in a major take-private deal.
Adcock Ingram is set to delist from the JSE as Natco Pharma partners with Bidvest in a major take-private deal.